Can9 Bioengineering Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Can9 Bioengineering General Information

Description

Provider of biotechnology research services intended to focus on genetics research in canines. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 348 West 49th Street
  • Apartment 5B
  • New York, NY 10019
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 348 West 49th Street
  • Apartment 5B
  • New York, NY 10019
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Can9 Bioengineering Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Feb-2026 Completed Stealth
To view Can9 Bioengineering’s complete valuation and funding history, request access »

Can9 Bioengineering Patents

Can9 Bioengineering Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026167593-A1 Generation of genetically-modified dogs with reduced allergic response in humans Pending 06-Feb-2025

Can9 Bioengineering Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Can9 Bioengineering Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xfund Venture Capital Minority
To view Can9 Bioengineering’s complete investors history, request access »

Can9 Bioengineering FAQs

  • When was Can9 Bioengineering founded?

    Can9 Bioengineering was founded in 2019.

  • Where is Can9 Bioengineering headquartered?

    Can9 Bioengineering is headquartered in New York, NY.

  • What is the size of Can9 Bioengineering?

    Can9 Bioengineering has 2 total employees.

  • What industry is Can9 Bioengineering in?

    Can9 Bioengineering’s primary industry is Biotechnology.

  • Is Can9 Bioengineering a private or public company?

    Can9 Bioengineering is a Private company.

  • What is Can9 Bioengineering’s current revenue?

    The current revenue for Can9 Bioengineering is .

  • Who are Can9 Bioengineering’s investors?

    Xfund has invested in Can9 Bioengineering.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process